Xiaoxia Guo - Publications

D-xylose suppresses hepatocellular carcinoma progression by regulating dihydrodiol dehydrogenase and remodeling the immune microenvironment.

Journal: Frontiers in immunology

Published: January 20, 2026

Dual Role of PSMB9 Linking Immune Activation and Tumor Adaptation in Hepatocellular Carcinoma With Therapeutic and Prognostic Implications.

Journal: Anticancer research

Published: December 12, 2025

MRI-based clinical-radiomics-habitat model for predicting prognosis of hepatocellular carcinoma patients treated with HAIC.

Journal: Frontiers in oncology

Published: December 09, 2025

The effects of irreversible electroporation triggering anti-tumor immunity and the value of its combination with immunotherapy.

Journal: Journal of interventional medicine

Published: February 21, 2023

Tumor-infiltrating OX40+ lymphocytes is an independent positive prognostic factor for patients with pancreatic ductal adenocarcinoma.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: December 02, 2021

Immunological effect of irreversible electroporation on hepatocellular carcinoma.

Journal: BMC cancer

Published: October 21, 2020

Thermally sensitive fluorescence imaging system for radiofrequency ablation guidance.

Journal: International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group

Published: April 02, 2020

Renal artery assessment with non-enhanced MR angiography versus digital subtraction angiography: comparison between 1.5 and 3.0 T.

Journal: European radiology

Published: February 28, 2019

Molecular Imaging of Pancreatic Duct Adenocarcinoma Using a Type 2 Cannabinoid Receptor-Targeted Near-Infrared Fluorescent Probe.

Journal: Translational oncology

Published: April 30, 2018